Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection (Q74532762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

ultraviolet radiation

0 references

high-performance liquid chromatography

1 reference

M L Foisy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J P Sommadossi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

Journal of Chromatography B: Biomedical Sciences and Applications

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

721

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

239-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

11 November 2019

high-performance liquid chromatography

1 reference

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2898%2900451-4

7 January 2021

HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2898%2900451-4

7 January 2021

High-performance liquid chromatographic determination of a potent and selective HIV protease inhibitor (L-735,524) in rat, dog and monkey plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2898%2900451-4

7 January 2021

Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2898%2900451-4

7 January 2021

Simultaneous determination of unlabeled and deuterium-labeled indinavir in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2898%2900451-4

7 January 2021

Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2898%2900451-4

7 January 2021

10.1016/S0378-4347(98)00451-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052696%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference